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ABSTRACT: A direct enantioselective synthesis of substi-
tuted oxygen heterocycles from lactol acetates and 
enolsilanes has been realized using a highly reactive and 
confined imidodiphosphorimidate (IDPi) catalyst. Various 
chiral oxygen heterocycles, including tetrahydrofurans, 
tetrahydropyrans, oxepanes, chromans, and dihydrobenzo-
furans were obtained in excellent enantioselectivities by 
reacting the corresponding lactol acetates with divers enol 
silanes. Mechanistic studies suggest the reaction to pro-
ceed via a non-stabilized, aliphatic, cyclic oxocarbenium ion 
intermediate paired with the confined chiral counteranion.  
Oxocarbenium ions are key intermediates in enzymatic 
glycosidations but also in a variety of synthetic transfor-
mations.
1
 The stereocontrol of such reactions is challenging 
and catalytic enantioselective approaches have only recent-
ly been described.
2
 Asymmetric nucleophilic substitutions 
via non-aromatic, cyclic oxocarbenium ions are particularly 
difficult to control as these cations neither display Lewis 
basic sites nor large π-surfaces for substrate-catalyst inter-
actions. We show here that silylium-based, asymmetric 
counteranion directed Lewis acid catalysis provides a gen-
eral solution to this challenge; various lactol acetates react 
with enol silanes in the presence of a highly active and 
confined pre-Lewis acid organocatalyst to furnish substitut-
ed oxygen heterocycles in high enantioselectivity. 
 
Despite the frequent appearance of saturated oxygen het-
erocycles in drugs and natural products,
3
 general methods 
for their enantioselective synthesis are relatively rare.
4−11
 
One straight forward approach is the direct addition of nu-
cleophiles to in situ generated cyclic oxocarbenium ions. In 
pioneering studies, Braun et al. showed that a chiral titani-
um complex enables the dynamic kinetic asymmetric nucle-
ophilic substitution of allyltrimethylsilane with silyl ethers 
and acetals.
2a
 However, high enantioselectivity was only 
achieved with aromatic substrates. Recently, the Jacobsen 
group reported enantioselective substitution reactions of 
silyl ketene acetals with aromatic glycosyl chlorides using 
anion binding catalysis.
2b,2r−t
 Chiral 1-substituted isochrom-
anes and related products were also obtained via oxidative 
enamine catalysis, via alkynylation using a chiral copper 
catalyst combined with stoichiometric Lewis acids, via chiral 
silver salt catalyzed reductions, and via nucleophilic addition 
reactions to pyrylium salts using different catalysts.
2c-o
 Most 
recently, the Mattson group developed a silandiol catalyzed 
chromenone functionalization
2p
 and the Toste group utilized 





All these examples are limited to the use of resonance 
stabilized oxocarbenium ions within six membered ring 
systems. In contrast, the enantioselective formation of tet-
rahydrofurans or tetrahydropyrans via nucleophilic addition 
reactions to aliphatic, cyclic oxocarbenium ions remained as 
a long-standing challenge. Their high electrophilicity often 
leads to catalyst degradation and their small size and the 
absence of further functionalization makes enantiodifferen-
tiation difficult to accomplish. We have recently introduced 
confined imidodiphosphoric acid catalysts (IDPs) that cata-
lyze cyclization reactions via aliphatic oxocarbenium ions.
12
 
However, intermolecular reactions proceeding via unmodi-
fied, aliphatic, cyclic oxocarbenium ions could not be ac-
complished with these catalysts. We envisioned that our 
newly developed imidodiphosphorimidates (IDPi) could 
perhaps provide a solution to this significant problem.
13
 
Their acidity is higher than that of IDPs and even of disul-
fonimides (DSIs), enabling silylium-based asymmetric coun-
teranion directed catalysis (Si-ACDC).
14,15
 In addition, their 
highly stabilized counteranions should support the genera-
tion of ion pairs with strongly electrophilic cations. Finally, 
the confined active site should allow an efficient enantiodis-
crimination of sterically and electronically unbiased cationic 
intermediates. Based on these considerations, a plausible 
catalytic cycle can be envisioned (eq. 1), which is initiated 
with the in situ generation of the silylium ion pair catalyst 
from the strongly Brønsted acidic precatalyst HX* and a 
silylated nucleophile (TBS-Nu).  
 
 
 The cyclic oxocarbenium ion is subsequently generated via 
acetate abstraction from a lactol acetate by the silicon Lewis 
acid.
16
 In the following nucleophilic addition of the silylated 
nucleophile to the oxocarbenium ion, the counteranion 
directs the enantiodifferentiation leading to formation of the 
product and the regeneration of the silylium Lewis acid 
catalyst. 
 
To test this design, we explored the reaction of different 
oxocarbenium ion precursors 1 with ketene acetal 2a in the 
presence of a variety of acidic catalysts previously devel-
oped in our group (Table 1). Chiral disulfonimide catalyst 4 
enabled full conversion to the desired product 3a within 4 h, 
but without any enantioselectivity (entry 1). In contrast, 
imidodiphosphate catalyst 5 gave no conversion, likely due 
to its insufficient acidity. Remarkably however, IDPi catalyst  
 




entry substrate catalyst Temp conv.b er 
1
c,d
 1a 4 r.t. >95 50:50 
2
c,d
 1a 5 r.t. <10 ND 
3
c
 1a 6a r.t. >95 59.5:40.5 
4 1a 6a r.t. >95 61.5:18.5 
5 1a 6b 20 °C >95 60:40 
6 1a 6c 20 °C >95 84:16 
7 1a 6d 20 °C >95 94:6 
8 1b 6d 20 °C >95 93:7 
9 1c 6d 20 °C >95
e 87:13 
10 1a 6d  °C >95 97:3 
11
f
 1a 6d  °C >95 98:2 
12
f,g
 1a 6d  °C >95(88)
h 98:2 
a
Unless otherwise indicated, reactions were conducted on 0.05 
mmol scale with 3.0 equiv. of 2a and 1.0 mol% of catalyst in 0.5 mL 





mined by NMR with an internal standard. 
c
Reaction was carried out 
in CH2Cl2 
d
5 mol% catalyst. 
e
19% of product was observed in crude 
NMR 
f
1.2 equiv. nucleophile 
g
1.0 mmol scale, 0.1 mol% catalyst 
h
isolated yield; ND=not determined 
6a efficiently promoted the reaction with promising enanti-
oselectivity (entries 3, 4). The corresponding 2-naphtyl 
substituted catalyst 6b, previously used in the asymmetric 
Hosomi-Sakurai allylation of aldehydes, showed no im-
provement in enantioselectivity (entry 5). We found that 
para-substituents at the 3,3’-phenyl-groups of the BINOL-
backbone strongly affect the enantioselectivity. Stepwise er 
increase was observed by varying from the small methyl to 
the bulky tert-butyl groups, affording up to 94:6 er at −20 °C 
in toluene (entries 6, 7). Switching from acetate 1a to ben-
zoate 1b did not influence reactivity or selectivity (entry 8)  
and 2-chlorotetrahydrofuran 1c gave only 19% of the prod-
uct and reduced enantioselectivity. The selectivity was 
further increased to 97:3 er by lowering the temperature to 
−78 °C (entry 10). Furthermore, the amount of nucleophile 
could be reduced to 1.2 equiv. without affecting enantiose-
lectivity or conversion (entry 11). Under the optimal condi-
tion, as little as 0.1 mol% of catalyst 6d was sufficient to 
furnish tetrahydrofuran 3a in 88% yield after 16 hours (entry 
12). It is noteworthy that product 3a is the staring material of 
several syntheses of biologically active materials but there 
are only a few preparative procedures for its synthesis, 




With the optimal condition in hand, we next investigated the 
reaction scope (Table 2). Various nucleophiles and electro-
philes can be utilized in our reaction. The size of the nucle-
ophile does not seem to influence selectivity and reactivity 
much (entries 1-3). In addition to silyl ketene acetals, the 
silyl enol ether derived from acetophenone (2d) was also 
applicable, although with slightly lower enantioselectivity 
(entry 4). A conjugated silyl enol ether gave product 3e in 
high enantioselectivity (entry 5). Extended nucleophiles 
such as vinylogous ketene acetal 2f and dioxinone-derived 
silyloxydiene 2g reacted at the γ-position, furnishing the 
corresponding heterocycles with more than 95:5 er and in 
moderate to excellent yields (entries 6, 7). Tetrahydropyran 
and oxepane products 3h and 3i could be obtained under 
identical conditions with high enantiomeric ratios from the 
corresponding 6- and 7-membered lactol acetates (entries 
8, 9). In addition to simple aliphatic substrates, aromatic 
substrates possessing chroman and benzodihydrofuran 
moieties could also be converted under our reaction condi-
tions, but required longer reaction times and higher concen-
tration. Full conversion to products 3j and 3k with excellent 
and good enantioselectivity was observed after seven and 
four days respectively (entries 10, 11). In contrast, the reac-
tion with 1-acetoxyisochroman 1h was completed within 10 
min and gave product 3l in high yield, but with only moder-
ate enantioselectivity (entry 12). 
 
Remarkably, when 2,4-bis(acetoxy)-tetrahydrofuran 1i was 
subjected to reaction conditions using 2.4 equiv. of nucleo-
phile 2b, the entire mixture of stereoisomers (meso-1i, S,S-
1i, and R,R-1i) was converted into a single major product 
stereoisomer (Eq 2). The initial 1.5:1 racemic trans to cis 
ratio of substrate 1i gave a 15:1 trans to cis ratio in product 
3m, which was obtained with superb enantiomeric ratio 
(>99:1) in a diasteroconvergent and enantioconvergent 
kinetic resolution. We were also able to utilize α-branched 
nuclophiles. For example, 2-(trimethylsiloxy)furan (2h) re-
 acted with lactol acetate 1a to give lactone product syn-3n 
with excellent er and moderate dr (Eq 3).
18 
 































2b 80 96.5:3.5 
9 
3i 
2b 91 97:3 
10d,e 
3j 
2b 43 98.5:1.5 
11d,f 
3k 
2b 96 94.5:5.5 
12g 
3l 
2a 73 67:33 
a
Unless otherwise indicated, reactions were conducted with 1.0  
equiv. of substrates, 1.2 equiv. of nucleophile and 1.0 mol% of 
catalyst in toluene (0.1 M). Er was determined by HPLC and GC. 
b
1.0 mmol scale, 0.1 mol% catalyst.
 c












Towards elucidating the mechanism of our reaction, we 
have determined enantiomeric excesses of substrate 1a 
and product 3a during the course of the reaction. While the 
enantiomeric excess of the product was constantly high 
from the beginning of the reaction, not unexpectedly, one 
enantiomer of substrate 1a reacted faster than the other, 
affording a gradual enrichment of enantiomeric excess of 
the substrate. This phenomenon well corresponds to a 
theoretical graph using the equation of Kagan,
19
 with a 
selectivity factor s of ca. 4. Both, the decrement of reaction 
rate by electron deficiency on oxygen (Table 2, entries 10, 
11) and the fact that both enantiomers are converted into 
the same enantiopure product are consistent with an SN1 
mechanism involving a cyclic oxocarbenium ion intermedi-






Figure 1. Proposed Mechanism and Enantiomeric Excess 


















ln⁡[(1 − c)(1 − eesm)]
ln⁡[⁡(1 − c)(1 + eesm)]
 
 In conclusion, we have developed a catalytic enantioselec-
tive synthesis of oxygen containing heterocycles from readi-
ly accessible lactol acetate precursors and silylated nucleo-
philes. We suggest the reaction to proceed via an ACDC-
type SN1-mechanism involving a non-stabilized, aliphatic, 
cyclic oxocarbenium ion paired to the confined IDPi coun-
teranion. The scope of our reaction is broad, and five, six, 
and seven-membered ring lactol acetates react with various 
nucleophiles. Moreover, our catalyst system also tolerates 
aromatic substrates furnishing chroman and dihydrobenzo-
furan products. Finally, a highly diastereo- and enantiocon-
vergent catalytic asymmetric transformation has been real-
ized with substrate 1h and provided a C2-symmetric tetra-
hydrofuran product.  
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